Last edition
News about "Urticaria treatment"
Cadila Pharmaceuticals Introduces Dlorfast-M Tablets to Treat Allergic Rhinitis and Urticaria
Allergic rhinitis and urticaria are chronic health conditions that affect millions of people globally. Cadila Pharmaceuticals has introduced Dlorfast-M as a dual-action therapy targeting two pathways of the allergic response—histamine and leukotriene—aiming to provide wider and more effective symptom management.
Urticaria Treatment | 14/10/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members